Overview

Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether mycophenolate mofetil is effective as treatment for new cases of ANCA associated vasculitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborators:
Aspreva Pharmaceuticals
Vifor Pharma
Treatments:
Cyclophosphamide
Mycophenolate mofetil
Mycophenolic Acid